Venus Concept Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2025 to a ratio of 2.53, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the third quarter 2025. Average receivable collection period, for the Venus Concept Inc in Sep 30 2025 quarter, has decreased to 144 days, compared to 150 days, in the Jun 30 2025 quarter.

If we take a look into Healthcare sector 203 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2025 from 1229 to 1538.

What is Receivable Turnover Ratio?
What is Venus Concept Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VERO Receivables Turnover Ratio	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Receivable Change	-21.79 %	-35.86 %	-38.23 %	-35.78 %	-38.26 %
Y / Y Revenue Change	-10.11 %	-24.68 %	-22.87 %	-11.45 %	-17.17 %
Receivable Turnover Ratio (TTM)	2.53	2.43	2.34	2.2	2.04
VERO's Total Ranking	# 1538	# 1229	# 2907	# 1560	# 3178
Accounts Receivable average collection period days	144	150	156	166	179
Seq. Receivable Change	4.67 %	-6.05 %	-10.36 %	-11.28 %	-14.16 %
Seq. Revenue Change	-5.89 %	6.93 %	-24.32 %	18.02 %	-21.14 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 86
Healthcare Sector	# 204
Overall Market	# 1538

Receivable Turnover Ratio Statistics
High	Average	Low
1.67	0.67	0.03
(Dec 31 2019)		(Sep 30 2017)

VERO Company Profile • Back to VERO Efficiency Comparisons • Compare VERO Receivables Turnover Ratio to its Competitors

Financial Statements
Venus Concept Inc 's Accounts Receivable	$ 17 Millions	Visit VERO's Balance sheet
Venus Concept Inc 's Sales TTM	$ 43 Millions	Visit VERO's Income Statement
Sources of VERO's Revenues		Visit VERO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VERO's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VERO's Growth Rates	VERO's Roa	VERO's Inventory Turnover Ratio	VERO's Dividend Comparisons
VERO's Profitability Ratios	VERO's Roi	VERO's Asset Turnover Ratio	VERO's Dividend Growth
VERO's Valuation Ratios	VERO's Roe	VERO's Financial Strength Ratios	VERO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2025	Receivable at quarter ending Sep 30 2025
Nephros Inc	7.14	$ 16.339 Millions	$ 2.290 Millions
Aurinia Pharmaceuticals Inc	7.14	$ 265.808 Millions	$ 37.253 Millions
Dariohealth Corp	7.13	$ 23.063 Millions	$ 3.236 Millions
Bionano Genomics Inc	7.12	$ 28.720 Millions	$ 4.031 Millions
Boston Scientific Corporation	7.10	$ 19,350.000 Millions	$ 2,723.500 Millions
Cannapharmarx Inc	7.05	$ 1.706 Millions	$ 0.242 Millions
Beyond Air Inc	7.04	$ 4.795 Millions	$ 0.681 Millions
Avita Medical Inc	7.01	$ 72.400 Millions	$ 10.325 Millions
Medpace Holdings Inc	7.01	$ 2,358.373 Millions	$ 336.404 Millions
Elutia Inc	6.99	$ 20.692 Millions	$ 2.960 Millions
3m Company	6.98	$ 24,825.000 Millions	$ 3,558.000 Millions
Nuo Therapeutics Inc	6.98	$ 2.612 Millions	$ 0.374 Millions
Hca Healthcare Inc	6.96	$ 74,372.000 Millions	$ 10,681.500 Millions
Ceribell Inc	6.95	$ 81.165 Millions	$ 11.681 Millions
Tela Bio Inc	6.93	$ 74.807 Millions	$ 10.791 Millions
Angiodynamics Inc	6.92	$ 298.778 Millions	$ 43.153 Millions
Solventum Corporation	6.92	$ 8,402.000 Millions	$ 1,213.750 Millions
Vaso Corporation	6.92	$ 89.198 Millions	$ 12.894 Millions
Pavmed Inc	6.91	$ 0.057 Millions	$ 0.008 Millions
Natera Inc	6.89	$ 2,116.674 Millions	$ 307.000 Millions
Phibro Animal Health Corporation	6.89	$ 1,400.230 Millions	$ 203.212 Millions
Edwards Lifesciences Corporation	6.84	$ 5,599.100 Millions	$ 818.675 Millions
Carlisle Companies Incorporated	6.83	$ 5,015.100 Millions	$ 733.775 Millions
Koru Medical Systems Inc	6.83	$ 39.071 Millions	$ 5.718 Millions
Sangamo Therapeutics Inc	6.81	$ 32.875 Millions	$ 4.827 Millions
Enhabit Inc	6.79	$ 1,047.800 Millions	$ 154.325 Millions
Adm Tronics Unlimited Inc	6.78	$ 3.360 Millions	$ 0.495 Millions
Merit Medical Systems Inc	6.78	$ 1,476.901 Millions	$ 217.826 Millions
Biocryst Pharmaceuticals Inc	6.76	$ 599.816 Millions	$ 88.741 Millions
Cerus Corporation	6.75	$ 197.924 Millions	$ 29.322 Millions

Date modified: 2026-09-12T06:22:54+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.